NATL HEALTH INVESTORS INC (NHI) Fundamental Analysis & Valuation

NYSE:NHI • US63633D1046

Current stock price

83 USD
-0.12 (-0.14%)
Last:

This NHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NHI Profitability Analysis

1.1 Basic Checks

  • NHI had positive earnings in the past year.
  • In the past year NHI had a positive cash flow from operations.
  • In the past 5 years NHI has always been profitable.
  • Each year in the past 5 years NHI had a positive operating cash flow.
NHI Yearly Net Income VS EBIT VS OCF VS FCFNHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • NHI has a better Return On Assets (5.08%) than 93.50% of its industry peers.
  • NHI has a better Return On Equity (9.33%) than 84.55% of its industry peers.
  • NHI has a better Return On Invested Capital (5.56%) than 95.12% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NHI is above the industry average of 3.13%.
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROIC 5.56%
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
NHI Yearly ROA, ROE, ROICNHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of NHI (37.80%) is better than 91.87% of its industry peers.
  • In the last couple of years the Profit Margin of NHI has declined.
  • NHI has a Operating Margin of 50.74%. This is amongst the best in the industry. NHI outperforms 93.50% of its industry peers.
  • NHI's Operating Margin has declined in the last couple of years.
  • NHI has a better Gross Margin (80.86%) than 82.11% of its industry peers.
  • NHI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
NHI Yearly Profit, Operating, Gross MarginsNHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NHI Health Analysis

2.1 Basic Checks

  • NHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NHI has been increased compared to 1 year ago.
  • The number of shares outstanding for NHI has been increased compared to 5 years ago.
  • NHI has a better debt/assets ratio than last year.
NHI Yearly Shares OutstandingNHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NHI Yearly Total Debt VS Total AssetsNHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • NHI has an Altman-Z score of 2.06. This is not the best score and indicates that NHI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 2.06, NHI belongs to the best of the industry, outperforming 95.94% of the companies in the same industry.
  • A Debt/Equity ratio of 0.76 indicates that NHI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of NHI (0.76) is better than 74.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 2.06
ROIC/WACC0.72
WACC7.75%
NHI Yearly LT Debt VS Equity VS FCFNHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • NHI has a Current Ratio of 1.19. This is a normal value and indicates that NHI is financially healthy and should not expect problems in meeting its short term obligations.
  • NHI's Current ratio of 1.19 is fine compared to the rest of the industry. NHI outperforms 64.23% of its industry peers.
  • NHI has a Quick Ratio of 1.19. This is a normal value and indicates that NHI is financially healthy and should not expect problems in meeting its short term obligations.
  • NHI's Quick ratio of 1.19 is fine compared to the rest of the industry. NHI outperforms 65.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
NHI Yearly Current Assets VS Current LiabilitesNHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. NHI Growth Analysis

3.1 Past

  • NHI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.34%.
  • The Earnings Per Share has been decreasing by -6.07% on average over the past years.
  • NHI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.07%.
  • The Revenue has been growing slightly by 2.45% on average over the past years.
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%

3.2 Future

  • NHI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.45% yearly.
  • The Revenue is expected to grow by 14.69% on average over the next years. This is quite good.
EPS Next Y11.53%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
EPS Next 5YN/A
Revenue Next Year16.12%
Revenue Next 2Y11.8%
Revenue Next 3Y14.74%
Revenue Next 5Y14.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NHI Yearly Revenue VS EstimatesNHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
NHI Yearly EPS VS EstimatesNHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. NHI Valuation Analysis

4.1 Price/Earnings Ratio

  • NHI is valuated quite expensively with a Price/Earnings ratio of 27.48.
  • Compared to the rest of the industry, the Price/Earnings ratio of NHI indicates a somewhat cheap valuation: NHI is cheaper than 68.29% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.61. NHI is around the same levels.
  • NHI is valuated rather expensively with a Price/Forward Earnings ratio of 24.64.
  • 84.55% of the companies in the same industry are more expensive than NHI, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.79. NHI is around the same levels.
Industry RankSector Rank
PE 27.48
Fwd PE 24.64
NHI Price Earnings VS Forward Price EarningsNHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • NHI's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. NHI is more expensive than 80.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.03
NHI Per share dataNHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NHI does not grow enough to justify the current Price/Earnings ratio.
  • NHI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.38
PEG (5Y)N/A
EPS Next 2Y6.79%
EPS Next 3Y3.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. NHI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.34%, NHI is a good candidate for dividend investing.
  • NHI's Dividend Yield is comparable with the industry average which is at 7.32.
  • Compared to an average S&P500 Dividend Yield of 1.89, NHI pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.34%

5.2 History

  • The dividend of NHI decreases each year by -3.59%.
  • NHI has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of NHI decreased in the last 3 years.
Dividend Growth(5Y)-3.59%
Div Incr Years0
Div Non Decr Years2
NHI Yearly Dividends per shareNHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • NHI pays out 119.52% of its income as dividend. This is not a sustainable payout ratio.
DP119.52%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
NHI Yearly Income VS Free CF VS DividendNHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M
NHI Dividend Payout.NHI Dividend Payout, showing the Payout Ratio.NHI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NHI Fundamentals: All Metrics, Ratios and Statistics

NATL HEALTH INVESTORS INC

NYSE:NHI (3/26/2026, 12:27:38 PM)

83

-0.12 (-0.14%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners73.45%
Inst Owner Change-0.55%
Ins Owners0.9%
Ins Owner Change14.89%
Market Cap4.02B
Revenue(TTM)375.63M
Net Income(TTM)141.98M
Analysts76.67
Price Target87.34 (5.23%)
Short Float %2.63%
Short Ratio4.6
Dividend
Industry RankSector Rank
Dividend Yield 4.34%
Yearly Dividend3.61
Dividend Growth(5Y)-3.59%
DP119.52%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.1%
Min EPS beat(2)-8.3%
Max EPS beat(2)-1.91%
EPS beat(4)1
Avg EPS beat(4)-1.5%
Min EPS beat(4)-8.3%
Max EPS beat(4)4.29%
EPS beat(8)4
Avg EPS beat(8)0.17%
EPS beat(12)6
Avg EPS beat(12)2.26%
EPS beat(16)7
Avg EPS beat(16)-10.94%
Revenue beat(2)2
Avg Revenue beat(2)8.55%
Min Revenue beat(2)5.78%
Max Revenue beat(2)11.32%
Revenue beat(4)4
Avg Revenue beat(4)6.17%
Min Revenue beat(4)3.26%
Max Revenue beat(4)11.32%
Revenue beat(8)8
Avg Revenue beat(8)5.58%
Revenue beat(12)11
Avg Revenue beat(12)4.1%
Revenue beat(16)12
Avg Revenue beat(16)1.1%
PT rev (1m)0%
PT rev (3m)-0.44%
EPS NQ rev (1m)-4.4%
EPS NQ rev (3m)-4.4%
EPS NY rev (1m)0%
EPS NY rev (3m)1.75%
Revenue NQ rev (1m)4.32%
Revenue NQ rev (3m)6.57%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)5.92%
Valuation
Industry RankSector Rank
PE 27.48
Fwd PE 24.64
P/S 10.69
P/FCF N/A
P/OCF 16.98
P/B 2.64
P/tB 2.64
EV/EBITDA 19.03
EPS(TTM)3.02
EY3.64%
EPS(NY)3.37
Fwd EY4.06%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)4.89
OCFY5.89%
SpS7.76
BVpS31.44
TBVpS31.44
PEG (NY)2.38
PEG (5Y)N/A
Graham Number46.22
Profitability
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROCE 7.04%
ROIC 5.56%
ROICexc 5.6%
ROICexgc 5.62%
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
FCFM N/A
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
ROICexc(3y)5.81%
ROICexc(5y)5.5%
ROICexgc(3y)5.84%
ROICexgc(5y)5.53%
ROCE(3y)7.29%
ROCE(5y)6.89%
ROICexgc growth 3Y6.24%
ROICexgc growth 5Y-1.2%
ROICexc growth 3Y6.24%
ROICexc growth 5Y-1.17%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA 4.29
Cap/Depr 363.26%
Cap/Sales 78.28%
Interest Coverage 3.7
Cash Conversion 87.12%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 2.06
F-Score5
WACC7.75%
ROIC/WACC0.72
Cap/Depr(3y)218.38%
Cap/Depr(5y)144.44%
Cap/Sales(3y)46.96%
Cap/Sales(5y)31.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
EPS Next Y11.53%
EPS Next 2Y6.79%
EPS Next 3Y3.45%
EPS Next 5YN/A
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%
Revenue Next Year16.12%
Revenue Next 2Y11.8%
Revenue Next 3Y14.74%
Revenue Next 5Y14.69%
EBIT growth 1Y1.11%
EBIT growth 3Y10%
EBIT growth 5Y-3.26%
EBIT Next Year58.98%
EBIT Next 3Y18.87%
EBIT Next 5YN/A
FCF growth 1Y-215.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.86%
OCF growth 3Y8.48%
OCF growth 5Y0.38%

NATL HEALTH INVESTORS INC / NHI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NATL HEALTH INVESTORS INC (NHI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NHI.


What is the valuation status for NHI stock?

ChartMill assigns a valuation rating of 2 / 10 to NATL HEALTH INVESTORS INC (NHI). This can be considered as Overvalued.


How profitable is NATL HEALTH INVESTORS INC (NHI) stock?

NATL HEALTH INVESTORS INC (NHI) has a profitability rating of 7 / 10.


What are the PE and PB ratios of NATL HEALTH INVESTORS INC (NHI) stock?

The Price/Earnings (PE) ratio for NATL HEALTH INVESTORS INC (NHI) is 27.48 and the Price/Book (PB) ratio is 2.64.


Is the dividend of NATL HEALTH INVESTORS INC sustainable?

The dividend rating of NATL HEALTH INVESTORS INC (NHI) is 4 / 10 and the dividend payout ratio is 119.52%.